Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Medtronic
Mallinckrodt
Johnson and Johnson
Fish and Richardson

Generated: March 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Bavituximab

« Back to Dashboard

US Patents for Bavituximab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bavituximab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Bavituximab ➤ Sign Up .beta.-glucan methods and compositions that affect the tumor microenvironment BIOTHERA, INC. (Eagan, MN) ➤ Sign Up
Bavituximab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Bavituximab ➤ Sign Up Method of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA) ➤ Sign Up
Bavituximab ➤ Sign Up Modulators of toll-like receptor 7 Gilead Sciences, Inc. (Foster City, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Bavituximab

Drugname Country Document Number Estimated Expiration Related US Patent
Bavituximab Canada 2900764 2033-02-08 ➤ Sign Up
Bavituximab European Patent Office 2954056 2033-02-08 ➤ Sign Up
Bavituximab Hong Kong 1218930 2033-02-08 ➤ Sign Up
Bavituximab Japan 2016509014 2033-02-08 ➤ Sign Up
Bavituximab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Deloitte
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.